换一批
换一批Adiponectin signals through Adiponectin Receptor 1 to reverse imatinib resistance in K562 human chronic myeloid leukemia cells.
第一作者：
Shenghao,Wu
第一单位：
Department of Hematology, The Dingli Clinical Institute of Wenzhou Medical University (Wenzhou Central Hospital), Wenzhou, Zhejiang 325000, China. Electronic address: shenghao_wu@126.com.
作者：
主题词
脂联素(Adiponectin);动物(Animals);抗肿瘤药(Antineoplastic Agents);苯甲酰胺类(Benzamides);细胞周期(Cell Cycle);细胞增殖(Cell Proliferation);剂量效应关系, 药物(Dose-Response Relationship, Drug);抗药性, 肿瘤(Drug Resistance, Neoplasm);融合蛋白质类, bcr-abl(Fusion Proteins, bcr-abl);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);K562细胞(K562 Cells);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);哌嗪类(Piperazines);蛋白激酶抑制剂(Protein Kinase Inhibitors);嘧啶类(Pyrimidines);RNA, 小分子干扰(RNA, Small Interfering);受体, 脂联素(Receptors, Adiponectin);时间因素(Time Factors)
DOI
10.1016/j.bbrc.2014.11.089
PMID
25475722
发布时间
2015-11-19
- 浏览57
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
